Dainippon Sumitomo Files For Pediatric Indication Of Metgluco In Japan
This article was originally published in PharmAsia News
Executive Summary
Dainippon Sumitomo filed an application in Japan for the approval of Metgluco (metformin) tablets for the treatment of type 2 diabetes in children.